Evogene Correlations
EVGN Stock | USD 1.43 0.01 0.69% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evogene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evogene moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Evogene Correlation With Market
Modest diversification
The correlation between Evogene and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Evogene and DJI in the same portfolio, assuming nothing else is changed.
Evogene |
Moving together with Evogene Stock
0.61 | DRMA | Dermata Therapeutics | PairCorr |
0.64 | VRAX | Virax Biolabs Group | PairCorr |
0.75 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against Evogene Stock
0.39 | DVAX | Dynavax Technologies | PairCorr |
0.34 | DTIL | Precision BioSciences Earnings Call This Week | PairCorr |
0.59 | VRTX | Vertex Pharmaceuticals | PairCorr |
0.56 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.38 | VTVT | vTv Therapeutics Trending | PairCorr |
0.34 | EDIT | Editas Medicine | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Evogene Stock performing well and Evogene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Evogene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
RCUS | 2.70 | (0.82) | 0.00 | (0.86) | 0.00 | 3.18 | 22.17 | |||
FATE | 5.01 | (1.17) | 0.00 | (0.65) | 0.00 | 9.29 | 22.21 | |||
SURF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PLUR | 2.57 | (0.05) | 0.00 | (0.16) | 0.00 | 5.86 | 14.82 | |||
LEXX | 3.98 | (0.47) | 0.00 | (0.36) | 0.00 | 7.24 | 22.45 | |||
NAVB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ZVSA | 4.60 | (0.09) | 0.00 | (0.16) | 0.00 | 12.03 | 38.26 | |||
BDRX | 4.50 | (0.85) | 0.00 | (0.55) | 0.00 | 10.02 | 52.99 | |||
ONCR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CANF | 2.90 | 0.22 | 0.06 | 0.15 | 3.15 | 6.29 | 25.19 |
Evogene Corporate Management
Rachel Gerber | Head Relations | Profile | |
Russ Putland | Vice Ltd | Profile | |
Amit res | Chief Ltd | Profile | |
Dan Gelvan | Chief Ltd | Profile | |
Dotan Borenstein | Chief Ltd | Profile | |
Yaron Eldad | Chief Officer | Profile |